Interview with Bill Mobbs discussing Full Year Results

ITL Health Group (ASX:ITD) is pleased to provide the opportunity to listen to an audio interview with Mr. Bill Mobbs, Executive Chairman, following the release of the Company’s Full Year Results today.

In the interview Mr. Mobbs covers:

The strong Full Year results
An update on the $3.3bn Blood Culture Testing Market
The positive year forecast for MyHealthTest
The exciting 12 months ahead for the Group

Click link for full interview:

https://boardroom.media/broadcast/?eid=5996888a182f6a5a0dbc28e0&p=c35fe15cf269d7c70462d60d32c45931

Read original article →

Essentials for Blood Management and Clinical Procedures

ITL BioMedical enables best clinical outcomes through innovative tools for blood management and clinical procedures. As a global provider of blood management and clinical procedure tools with a significant portfolio of intellectual property, we consistently look to the future and leverage input from healthcare markets worldwide to advance our products. Our world-class manufacturing facility and R&D lab develops and rigorously tests our advancements ensuring our innovations are designed with the utmost quality for introduction on a global basis.

Essentials for Blood Management and Clinical Procedures

Product Catalogue